about
CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cellsAlisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsPro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling patATM Signaling PathwayCDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.Pin1-mediated Sp1 phosphorylation by CDK1 increases Sp1 stability and decreases its DNA-binding activity during mitosis.Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cellsThe anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cellsRole of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.Crude extract of Euphorbia formosana induces apoptosis of DU145 human prostate cancer cells acts through the caspase-dependent and independent signaling pathway.Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1β/TNF.Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study.Human T-lymphotropic virus proteins and post-translational modification pathwaysKnockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells.Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs.CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotencyGenome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression.Skin equivalents: a tool for the discovery and validation of pharmacodynamic biomarkers.Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
P2860
Q27853338-DC43DF79-2686-4601-AB9A-464C92A1E1D8Q28385880-D58E5355-6FF5-4126-BAE9-A6FCE4024DE6Q28386389-69861221-1F09-40A0-926F-BF134E61F0C1Q28389986-EF361FAC-C106-4ABC-809A-9976D84B6D59Q30225510-5A94BA0B-65CF-461D-B14E-95496318AE3CQ33654819-93B04D81-9870-4907-87B0-E3A5F4FEA406Q34711884-1A4C3686-04A5-4AD4-BAD0-D24D3C46D7C8Q34977484-C308A3AB-7973-4BF0-A2D3-6D0544D6EB0CQ35043888-57CCDD54-C816-42CF-8AB1-2C42892BE557Q35076696-EE3356D4-C560-4F41-8989-BAF5CD91027AQ35115295-8DCCCDD1-105F-4C51-BA9F-DFABFFDEFD3BQ35677732-9DC68D59-B9D1-4CE4-9246-B5C122A5E9BFQ36246031-D6B8265C-3FDE-44E4-8448-3C0B24379488Q36324682-A5C72E79-307B-42F7-91D4-DE1C0C73E175Q37709442-4BA746BE-16F8-45CA-AE3C-089B913E4C5BQ38156859-29819C04-44BD-44FF-A951-A971A7ACD0F0Q38936969-429D08A9-864B-44B1-861D-C2C1B8A19795Q39029198-6E8689E9-E244-4C65-9FC4-7BAF472DF303Q39196885-A76263A9-775A-4821-A2E8-E1F1C8BED62BQ42328309-EC24B89C-5EF2-4564-BCEA-ED227488DBEAQ42778379-D43A8A5E-9016-4F55-B4A6-C0216700B38FQ42826642-1D893C15-9403-4BE0-B88B-3C9E5EA6C41DQ47602380-8D37871F-265F-47DD-B430-27FD47E63598Q49831580-C2E8B065-010B-4182-BE56-BFAA6EC42DDDQ55059350-3B0141EB-5F11-41CE-9381-738A3F44CA92
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cdc2: a monopotent or pluripotent CDK?
@ast
Cdc2: a monopotent or pluripotent CDK?
@en
Cdc2: a monopotent or pluripotent CDK?
@en-gb
Cdc2: a monopotent or pluripotent CDK?
@nl
type
label
Cdc2: a monopotent or pluripotent CDK?
@ast
Cdc2: a monopotent or pluripotent CDK?
@en
Cdc2: a monopotent or pluripotent CDK?
@en-gb
Cdc2: a monopotent or pluripotent CDK?
@nl
prefLabel
Cdc2: a monopotent or pluripotent CDK?
@ast
Cdc2: a monopotent or pluripotent CDK?
@en
Cdc2: a monopotent or pluripotent CDK?
@en-gb
Cdc2: a monopotent or pluripotent CDK?
@nl
P2860
P1433
P1476
Cdc2: a monopotent or pluripotent CDK?
@en
P2093
P2860
P304
P356
10.1111/J.1365-2184.2011.00753.X
P407
P577
2011-06-01T00:00:00Z